Substance use policy and practice in the Covid-19 pandemic
Learning from early pandemic responses through internationally comparative field data
Bibliographic Data
The COVID-19 pandemic has created an unprecedented natural experiment in drug policy, treatment delivery, and harm reduction strategies by exposing wide variation in public health infrastructures and social safety nets around the world. Using qualitative data including ethnographic methods, questionnaires, and semi-structured interviews with people who use drugs (PWUD) and Delphi-method with experts from field sites spanning 13 different countries, this paper compares national responses to substance use during the first wave of the COVID-19 pandemic. Field data was collected by the Substance Use x COVID-19 (SU x COVID) Data Collaborative, an international network of social scientists, public health scientists, and community health practitioners convened to identify and contextualise health service delivery models and social protections that influence the health and wellbeing of PWUD during COVID-19. Findings suggest that countries with stronger social welfare systems pre-COVID introduced durable interventions targeting structural drivers of health. Countries with fragmented social service infrastructures implemented temporary initiatives for PWUD led by non-governmental organisations. The paper summarises the most successful early pandemic responses seen across countries and ends by calling for greater systemic investments in social protections for PWUD, diversion away from criminal-legal systems toward health interventions, and integrated harm reduction, treatment and recovery supports for PWUD
Coronavirus disease 2019 (COVID-19 · Economic growth · Economics · Environmental health · Harm · Harm reduction · Infectious disease (medical specialty · Pandemic · Political science · Psychological intervention · Public health · Public relations · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Law · Medicine · Nursing · Opioid Use Disorder Treatment · Health Policy
Housing First
Buprenorphine Treatment Divide by Race/Ethnicity and Payment
Public health and international drug policy
The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016
Grounded theory, mixed methods, and action research
The perfect storm
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016
Qualitative research methodologies
Supervised injection facilities in Canada
Supervised injection services
Covid-19
Managing outbreaks of highly contagious diseases in prisons
Alcohol use in times of the Covid 19
Covid-19 and forced alcohol abstinence in India
The Growth of Incarceration in the United States
Factors Associated With Alcohol Dependence Among Adult Male Clients in Butabika Hospital, Uganda
Tackling the overdose crisis
Beyond Nimbyism
Covid-19 - Enacting a ‘new normal’ for people who use drugs
Coordination, cooperation, and creativity within harm reduction networks in Iran
Essential work, precarious labour
Safer opioid distribution in response to the Covid-19 pandemic
Drug Consumption Rooms
Overdose Prevention in the United States
What Can We Learn From The Portuguese Decriminalization of Illicit Drugs
Therapy without a prescription
| Unique citing works | 4 |
|---|---|
| Citations per year | 1,33 |
| Citation span | 2023 - 2025 (3) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 4 |